We are live on ! Find out more
FFVM

Founders Fund V Management Portfolio holdings

AUM $2.16M
1-Year Est. Return 77.37%
This Fund
S&P 500
This Quarter Est. Return
-23.7%
1 Year Est. Return
+77.37%
3 Year Est. Return
+859.57%
5 Year Est. Return
-74.2%
10 Year Est. Return
–
AUM
$1.3M
AUM Growth
-$416K
Cap. Flow
-$1.77M
Cap. Flow %
-136.44%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
UBX
Unity Biotechnology
UBX
+$1.77M

Sector Composition

Rank Sector Weight
1 Healthcare 95.07%
2 Technology 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMTI
1
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$1.16M 88.91%
3,611,615
– –
UBX
2
DELISTED
Unity Biotechnology
UBX
$80.2K 6.17%
49,172
-442,579
-90% -$1.77M
RGTI icon
3
Rigetti Computing
RGTI
$4.89B
$64.1K 4.93%
88,621
– –

Similar funds

NA
Newport Asia San Francisco, California $2.21M AUM
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
IVSFI
IA Venture Strategies Fund II New York $4.08M AUM 174.71% 1-Year Est. Return
MI
Motiv8 Investments Port St. Lucie, Florida $183K AUM 15.06% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return
FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
SNN
Shen Neil Nanpeng $36.3K AUM 179.45% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return

Founders Fund V Management's Q1 2023 Portfolio in Review

As of Q1 2023, Founders Fund V Management held 3 positions worth $1.3M, down 24% from $1.72M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Founders Fund V Management withdrew a net $1.77M in Q1 2023, reducing 1 holding. Its largest reduction was Unity Biotechnology, cutting an estimated $1.77M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 96% a quarter earlier, followed by Technology.

  • Founders Fund V Management's biggest Q1 2023 reduction was Unity Biotechnology, cutting an estimated $1.77M.
  • Founders Fund V Management's ten largest holdings make up 100% of its $1.3M portfolio in Q1 2023.
  • Founders Fund V Management opened 0 new positions and closed 0 in Q1 2023.
  • Founders Fund V Management's portfolio value fell 24% quarter-over-quarter to $1.3M.

Based on Founders Fund V Management's 13F filing for Q1 2023, filed 15 May 2023.